Pfizer Loses Bid to Recoup $75 Million Left Over From SEC Settlement
NEW YORK (Reuters) - A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S.
Yahoo3h
Dow Slips for a 4th Day. Tech Stocks Rally.
The Dow Jones Industrial Average slipped for its fourth trading day in a row, as the blue-chip index missed out on a rally ...
BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It.
Other drug manufacturers declined in the days following the nomination. Pfizer and Moderna have declined 6.9% and 6.2% ...
Apellis Pharmaceuticals (APLS) Receives a Buy from Jefferies
Jefferies analyst Akash Tewari maintained a Buy rating on Apellis Pharmaceuticals (APLS – Research Report) today and set a price target of ...
Zacks.com on MSN11h
These 4 Price-to-Sales Stocks Can Supercharge Your Portfolio Growth
Investing in stocks based on valuation metrics is considered a smart strategy. The price-to-earnings (P/E) ratio is often the go-to metric due to its simplicity and ease of use. However, the ...
Here are 4 biotech stocks that could get a boost from a more open FDA regulatory climate
Biotech-stock investing has one tough test for success - and it's about to get easier ...